Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6a86ec4321b3682fe1b78890265532da |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D519-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D519-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-04 |
filingDate |
2008-08-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2015-10-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_077085ff5a96ef974d3524238b3d82f7 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_78c8ec8815a0ca2abc73fdd94ee33fcd http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_aaa745e9d057b8ca26f917dbcde00aa5 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_282a256a071c66ba7196553cc1620af4 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2996a776470a19f4c8d8a0a4e917f194 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_47e417ddfa9fc7baae3070c483be73f2 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f63e8369bc16c1791aaefae5c3afb252 |
publicationDate |
2015-10-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
EP-2188289-B1 |
titleOfInvention |
(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-piperazines as kinase inhibitors for the treatment of cancer and inflammation |
priorityDate |
2007-08-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |